Back

Prognostic implications of family screening in Dilated and Arrhythmogenic Cardiomyopathies

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Arrhythmogenic cardiomyopathy and cardiac sarcoidosis Dilated Cardiomyopathy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Miss Eva Del Mestre

University of Trieste, Trieste (Italy)

6 More presentations in this session

Presentation thumbnail
Correlation between epsilon wave and late potentials in arrythmogenic right ventricular cardiomyopathy. Do late potentials define the epsilon wave?
Doctor U. Skrzypczynska-Banasik (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Influence of left ventricular ejection fraction, type of mutation and sex on malignant ventricular arrhythmias in dsp and flnc mutations
Doctor A. Perez Ferrandiz (Sant Joan d'Alacant, ES)
Abstract Slides Video
Presentation thumbnail
Arrhythmic risk stratification in patients with left ventricular ring-like scar
Doctor V. Parisi (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Arrhythmogenic cardiomyopathy phenotype associated with the pathogenic founder variant c.1211dup in PKP2
Mr T. Bos (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Genetic testing in presumed cardiac sarcoidosis
Doctor M. Castrichini (Trieste, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmogenic cardiomyopathy and cardiac sarcoidosis

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Subclinical myocardial phenotype in genotype-positive relatives attending clinical and genetic screening for familial dilated cardiomyopathy
thumbnail
Congress Presentation
Exploring the diagnostic yield of family screening and genetic testing in adolescent individuals with pre-clinical phenotypes
thumbnail
Congress Presentation
Optimizing screening intervals for at-risk family members of dilated cardiomyopathy carrying a titin truncating variant: a multi-state model approach

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources